Rajthanee Hospital Public Company Limited (RJH.BK)
- Previous Close
11.90 - Open
12.00 - Bid --
- Ask --
- Day's Range
11.90 - 12.20 - 52 Week Range
11.80 - 26.25 - Volume
431,823 - Avg. Volume
827,289 - Market Cap (intraday)
3.519B - Beta (5Y Monthly) --
- PE Ratio (TTM)
7.27 - EPS (TTM)
1.65 - Earnings Date Aug 7, 2025 - Aug 11, 2025
- Forward Dividend & Yield 0.70 (5.83%)
- Ex-Dividend Date Mar 10, 2025
- 1y Target Est
13.50
Rajthanee Hospital Public Company Limited, together with its subsidiaries, provides healthcare services in Thailand. The company operates medical centers, including trauma emergency and neurosurgery, non-trauma emergency, cardiology, minimally invasive surgery, surgery, orthopedic, wellness and occupational health, radiology, MRI, ophthalmology, hemodialysis, sleep lab, dental, physical therapy, and laboratory centers. It also operates medical clinics, such as hematology, nephrology, arthritis and rheumatic, dermatology, allergy and immunology, oncology and chemotherapy, stroke, endocrinology, pulmonary, gastrointestinal and liver diseases, pediatrics, maternal and fetal medicine, obstetrics and gynecology, otolaryngology, psychiatric, and screening clinic for respiratory diseases. In addition, the company generates and sells solar power. Rajthanee Hospital Public Company Limited was incorporated in 1990 and is headquartered in Phra Nakhon Si Ayutthaya, Thailand.
www.rajthanee.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RJH.BK
View MorePerformance Overview: RJH.BK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RJH.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RJH.BK
View MoreValuation Measures
Market Cap
3.52B
Enterprise Value
4.98B
Trailing P/E
7.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.31
Price/Book (mrq)
1.73
Enterprise Value/Revenue
1.82
Enterprise Value/EBITDA
7.18
Financial Highlights
Profitability and Income Statement
Profit Margin
15.80%
Return on Assets (ttm)
6.87%
Return on Equity (ttm)
17.97%
Revenue (ttm)
2.79B
Net Income Avi to Common (ttm)
440.28M
Diluted EPS (ttm)
1.65
Balance Sheet and Cash Flow
Total Cash (mrq)
172.78M
Total Debt/Equity (mrq)
65.94%
Levered Free Cash Flow (ttm)
-171.15M